Results overview: Found 8 records in 0.04 seconds.
Articles, 8 records found
Articles 8 records found  
1.
17 p, 2.9 MB The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming / Mendoza, Gracia (Instituto de Investigación Sanitaria de Aragón) ; González-Pastor, Rebeca (Universidad UTE. Centro de Investigación Biomédica) ; Sánchez, Juan Miguel (Imperial College London. National Heart and Lung Institute) ; Arce Cerezo, Altamira (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Quintanilla, Miguel (Universidad Autónoma de Madrid. Departamento de Bioquímica) ; Moreno-Bueno, Gema (Instituto de Salud Carlos III. Centro de Investigación Biomédica en Red) ; Pujol i Altarriba, Anna (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Belmar-López, Carolina (Universidad Privada San Juan Bautista) ; de Martino, Alba (Instituto de Investigación Sanitaria de Aragón) ; Riu, Efrén (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Rodriguez, Tristan A. (Imperial College London. National Heart and Lung Institute) ; Martin-Duque, Pilar (Universidad de Zaragoza. Departamento de Cirugía)
The induction of pluripotency by enforced expression of different sets of genes in somatic cells has been achieved with reprogramming technologies first described by Yamanaka's group. Methodologies for generating induced pluripotent stem cells are as varied as the combinations of genes used. [...]
2023 - 10.3390/cells12091338
Cells, Vol. 12 (may 2023)  
2.
19 p, 9.6 MB Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation / Gámez-Chiachio, Manuel (Centro de Investigación Biomédica en Red de Cáncer) ; Molina-Crespo, Ángela (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Ramos-Nebot, Carmen (Centro de Investigación Biomédica en Red de Cáncer) ; Martinez-Val, Jeannette (Universidade de Santiago de Compostela) ; Martinez, Lidia (Universidad Autónoma de Madrid) ; Gassner, Katja (Mecanismos Moleculares Y Terapia Experimental en Oncologia-Programa OncobellIdibell (L'Hospitalet de Llobregat)) ; Llobet, Francisco J. (Mecanismos Moleculares Y Terapia Experimental en Oncologia-Programa OncobellIdibell (L'Hospitalet de Llobregat)) ; Soriano, Mario (Centro de Investigación Príncipe Felipe (València)) ; Hernandez, Alberto (Centro de Investigación Príncipe Felipe (València)) ; Cordani, Marco (Universidad Autónoma de Madrid) ; Bernadó Morales, Cristina (Vall d'Hebron Institut d'Oncologia) ; Diaz, Eva (Fundación MD Anderson Internacional (Madrid)) ; Rojo-Sebastian, Alejandro (Fundación MD Anderson Internacional (Madrid)) ; Triviño, Juan Carlos (Sistemas Genómicos) ; Sánchez-García, Laura (Mecanismos Moleculares Y Terapia Experimental en Oncologia-Programa OncobellIdibell (L'Hospitalet de Llobregat)) ; Rodríguez-Barrueco, Ruth (Universitat de Barcelona. Unitat d'Anatomia Humana i Embriologia) ; Arribas, Joaquín V (Vall d'Hebron Institut d'Oncologia) ; Llobet-Navás, David (Mecanismos Moleculares Y Terapia Experimental en Oncologia-Programa OncobellIdibell (L'Hospitalet de Llobregat)) ; Sarrió, David (Centro de Investigación Biomédica en Red de Cáncer) ; Moreno-Bueno, Gema (Fundación MD Anderson Internacional (Madrid)) ; Universitat Autònoma de Barcelona
Gasdermin B (GSDMB) over-expression promotes poor prognosis and aggressive behavior in HER2 breast cancer by increasing resistance to therapy. Decoding the molecular mechanism of GSDMB-mediated drug resistance is crucial to identify novel effective targeted treatments for HER2/GSDMB aggressive tumors. [...]
2022 - 10.1186/s13046-022-02497-w
Journal of Experimental & Clinical Cancer Research : CR, Vol. 41 (september 2022)  
3.
16 p, 5.4 MB Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression / Mota, Alba (Universidad Autónoma de Madrid. Departamento de Bioquímica) ; Oltra, Sara S. (Centro de Investigación Biomédica en Red de Cáncer) ; Selenica, Pier (Memorial Sloan Kettering Cancer Center) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Casas-Arozamena, Carlos (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; López-Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Diaz, Eva (MD Anderson International Foundation) ; Gatius, Sonia (Hospital Arnau de Vilanova (València)) ; Ruiz-Miro, María (Biobank (Lleida)) ; Calvo, Ana (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Rojo-Sebastián, Alejandro (MD Anderson Cancer Center) ; Hurtado Blanco, P (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Piñeiro, Health Research Institute of Santiago de Compostela ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ; Reis-Filho, Jorge S. (Memorial Sloan Kettering Cancer Center.) ; Muinelo-Romay, Laura (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Abal Posada, Miguel (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Matias-Guiu, Xavier (Universitat de Lleida) ; Weigelt, Britta (Memorial Sloan Kettering Cancer Center. Department of Pathology) ; Moreno-Bueno, Gema (Centro de Investigación Biomédica en Red de Cáncer) ; Universitat Autònoma de Barcelona
Analyzing different tumor regions by next generation sequencing allows the assessment of intratumor genetic heterogeneity (ITGH), a phenomenon that has been studied widely in some tumor types but has been less well explored in endometrial carcinoma (EC). [...]
2022 - 10.1038/s41388-022-02221-0
Oncogene, Vol. 41 (february 2022) , p. 1835-1850  
4.
16 p, 3.4 MB Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer / Casas-Arozamena, Carlos (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Diaz, Eva (Foundation MD Anderson International (Madrid)) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alonso-Alconada, Lorena (Nasasbiotech (La Coruña)) ; Ferreiros, Alba (Nasasbiotech (La Coruña)) ; Abalo, Alicia (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; López Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Oltra, Sara S. (Foundation MD Anderson International (Madrid)) ; de Santiago, Javier (Department of Gynecology, MD Anderson Cancer Center, 28029 Madrid, Spain) ; Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sampayo, Victoria (Complejo Hospitalario Universitario de Santiago de Compostela) ; Bouso, Marta (Complejo Hospitalario Universitario de Santiago de Compostela) ; Arias, Efigenia (Complejo Hospitalario Universitario de Santiago de Compostela) ; Cueva, Juan (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Colás Ortega, Eva (Centro de Investigación Biomédica en Red de Cáncer) ; Vilar, Ana (Complejo Hospitalario Universitario de Santiago de Compostela) ; Gil-Moreno, Antonio 1965- (Centro de Investigación Biomédica en Red de Cáncer) ; Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ; Moreno-Bueno, Gema (University of Madrid) ; Muinelo-Romay, Laura (Centro de Investigación Biomédica en Red de Cáncer) ; Universitat Autònoma de Barcelona
The incidence and mortality of endometrial cancer (EC) have risen in recent years, hence more precise management is needed. Therefore, we combined different types of liquid biopsies to better characterize the genetic landscape of EC in a non-invasive and dynamic manner. [...]
2020 - 10.3390/jcm9020585
Journal of clinical medicine, Vol. 9 (february 2020)  
5.
10 p, 621.9 KB Obesity and Breast Cancer : a Paradoxical and Controversial Relationship Influenced by Menopausal Status / García-Estévez, Laura (Centro de Investigación Biomédica en Red de Cáncer) ; Cortés, Javier (Vall d'Hebron Institut d'Oncologia) ; Pérez, Silvia (Breast Cancer Department, MD Anderson Cancer Center) ; Calvo Plaza, Isabel (Breast Cancer Department, MD Anderson Cancer Center) ; Gallegos, Isabel (Breast Cancer Department, MD Anderson Cancer Center) ; Moreno-Bueno, Gema (MD Anderson International Foundation) ; Universitat Autònoma de Barcelona
Breast cancer is the most common tumor in women worldwide, and an increasing public health concern. Knowledge of both protective and negative risk factors is essential for a better understanding of this heterogenous disease. [...]
2021 - 10.3389/fonc.2021.705911
Frontiers in Oncology, Vol. 11 (august 2021)  
6.
12 p, 2.5 MB Cancer network activity associated with therapeutic response and synergism / Serra-Musach, Jordi (Institut Català d'Oncologia) ; Mateo, Francesca (Institut Català d'Oncologia) ; Capdevila-Busquets, Eva (Institut de Recerca Biomèdica de Lleida) ; de Garibay, Gorka Ruiz (Institut Català d'Oncologia) ; Zhang, Xiaohu (National Center for Advancing Translational Sciences (Bethesda, Estats Units d'Amèrica)) ; Guha, Raj (National Center for Advancing Translational Sciences (Bethesda, Estats Units d'Amèrica)) ; Thomas, Craig J. (National Center for Advancing Translational Sciences (Bethesda, Estats Units d'Amèrica)) ; Grueso, Judit (Vall d'Hebron Institut d'Oncologia) ; Villanueva, Alberto (Institut Català d'Oncologia) ; Jaeger, Samira (Institut de Recerca Biomèdica de Lleida) ; Heyn, Holger (Institut d'Investigació Biomèdica de Bellvitge) ; Vizoso, Miguel (Institut d'Investigació Biomèdica de Bellvitge) ; Pérez Montero, Hector (Institut d'Investigació Biomèdica de Bellvitge) ; Cordero, Alex (Institut d'Investigació Biomèdica de Bellvitge) ; González Suarez, Eva (Institut d'Investigació Biomèdica de Bellvitge) ; Esteller, M. (Institució Catalana de Recerca i Estudis Avançats) ; Moreno-Bueno, Gema (Universidad Autónoma de Madrid. Departamento de Bioquímica) ; Tjärnberg, Andreas (Linköping University. Departament of Clinical and Experimental Medicine) ; Lázaro, Conxi (Institut Català d'Oncologia) ; Serra, Violeta (Vall d'Hebron Institut d'Oncologia) ; Arribas, Joaquín V. (Vicente) (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Benson, Mikael (Linköping University. Department of Clinical and Experimental Medicine) ; Gustafsson, Mika (Linköping University. Department of Clinical and Experimental Medicine) ; Ferrer, Marc (National Center for Advancing Translational Sciences (Bethesda, Estats Units d'Amèrica)) ; Aloy, Patrick (Institució Catalana de Recerca i Estudis Avançats) ; Pujana, Miquel Àngel (Institut Català d'Oncologia)
Cancer patients often show no or only modest benefit from a given therapy. This major problem in oncology is generally attributed to the lack of specific predictive biomarkers, yet a global measure of cancer cell activity may support a comprehensive mechanistic understanding of therapy efficacy. [...]
2016 - 10.1186/s13073-016-0340-x
Genome Medicine, Vol. 8 (August 2016) , ART. 88  
7.
14 p, 6.9 MB Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer / Hergueta-Redondo, Marta (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Sarrio, David (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Molina-Crespo, Ángela (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Vicario, Rocío (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bernadó Morales, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez, Lidia (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Rojo-Sebastián, Alejandro (Pathology Department, MD Anderson Cancer Center, Madrid, Spain) ; Serra-Musach, Jordi (Institut d'Investigació Biomèdica de Bellvitge) ; Mota, Alba (Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain) ; Martínez-Ramírez, Ángel (Cytogenetics Department, MD Anderson Cancer Center, Madrid, Spain) ; Castilla, Maria Ángeles (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; González-Martin, Antonio (Oncology Department, MD Anderson Cancer Center, Madrid, Spain) ; Pernas, Sonia (Institut d'Investigació Biomèdica de Bellvitge) ; Cano, Amparo (Universidad Autónoma de Madrid. Instituto de Investigaciones Biomédicas "Alberto Sols") ; Cortés, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nuciforo, Paolo. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Peg, Vicente (Hospital Universitari Vall d'Hebron) ; Palacios, José (Hospital Universitario Ramón y Cajal (Madrid)) ; Pujana, Miguel Ángel (Institut d'Investigació Biomèdica de Bellvitge) ; Arribas, Joaquín V (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moreno-Bueno, Gema (Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain) ; Universitat Autònoma de Barcelona
Around, 30-40% of HER2-positive breast cancers do not show substantial clinical benefit from the targeted therapy and, thus, the mechanisms underlying resistance remain partially unknown. Interestingly, ERBB2 is frequently co-amplified and co-expressed with neighbour genes that may play a relevant role in this cancer subtype. [...]
2016 - 10.18632/oncotarget.10787
Oncotarget, Vol. 7 (july 2016) , p. 56295-56308  
8.
18 p, 2.6 MB Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells / Castellana, Barbara (Departments of Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia) ; Aasen, Trond (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moreno-Bueno, Gema (Instituto de Investigaciones Biomédicas "Alberto Sols") ; Dunn, Sandra E. (Phoenix Molecular Diagnostics Ltd., Richmond) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Epithelial to mesenchymal transition (EMT) induces cell plasticity and promotes metastasis. The multifunctional oncoprotein Y-box binding protein-1 (YB-1) and the pleiotropic cytokine interleukin 6 (IL-6) have both been implicated in tumor cell metastasis and EMT, but via distinct pathways. [...]
2015 - 10.18632/oncotarget.5664
Oncotarget, Vol. 6 (october 2015) , p. 38239-38256  

See also: similar author names
1 Moreno-Bueno, G
2 Moreno-Bueno, G.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.